- Highlights
- Full Text
[1:31] ..." wonderful step forward talked about on your trials say is this a clinical trial at this point."...
[2:02] ..." own company tell me I I would imagine there are existing especially drug companies out there that might be very interested in your your work."...
[3:06] ..." I dedicate my time so eventually my plans to to pursue a professorship and and go and academia. To continue doing research -- of this kind. But over the next two years were really hoping"...
[3:43] ..." thank you very much I would I would do you hail from New England are you from --"...
[0:00]" Geoffrey Baum also on an MIT grad student and you are -- biomedical engineer Jeffrey and all so -- winner of the latest level some prize 30000 dollars. For urine innovations when it comes to cancer research tell us what you've been what you've been working on what you learned."
[0:17]" So had the chance to work on a number of different technologies and a couple of ninety. And two of them are in the area of cancer therapy. And visit to the primary ones that I think this award was given for. And the current state of cancer therapy is is that the -- treatments have remained a combination of chemotherapy and radiation for inoperable tumors and over 99% of the chemotherapy that's administered to patients doesn't go anywhere near the -- doesn't actually arrive at the tumors that. And that causes an immense amount talks need to patient patient off and can't work and care for their families. And so I sort of took two approaches to try to improve the stated that. First was to try to develop a new type of therapeutic. There would have a much lower toxicity so wouldn't matter -- 99% didn't go to the tumor the 1% the -- there. Would be very -- The second was to develop better ways of delivering existing drugs specifically to tumors so we did dial that 1% -- actually get there. Up to 10% -- up to 20%. That would substantially alleviate the off target effects that patients experience that are also considerably improve the toxicity -- exerted on the tumor."
[1:30]" What a wonderful step forward talked about on your trials say is this a clinical trial at this point."
[1:36]" No everything's been preclinical -- at this stage where we have some very promising data and months. And the next step for for both of these technologies will be pushing them forward. We found the company has passed ball club residents therapeutics that. Is encapsulate in both of these technologies and they aim of that the mission of that company is take this towards that it can benefit patients eventually."
[2:02]" You have your own company tell me I I would imagine there are existing especially drug companies out there that might be very interested in your your work."
[2:10]" Yeah it's it's a complicated. It's a complicated march taking something from the research bench and actually getting it. To work and anticipation -- we think the best way of doing that right now is set to start a company. And -- seeking the first stage investment and that companies that we can take the next step of scaling up. And getting this really so that is completely ready for prime time."
[2:34]" Obviously for your work you are being recognized by very prestigious award will be levels and MIT student -- 30000 dollars is this going to -- to your company."
[2:45]" So it's funny because -- as an incredible amount of money and as being someone who's been interested in innovation and development technologies and and -- on a seminary they have. -- considerable. Hopes that these technologies can move forward and this is about a by that would give me a lot of flexibility in the next two years in terms as. Where I dedicate my time so eventually my plans to to pursue a professorship and and go and academia. To continue doing research -- of this kind. But over the next two years were really hoping that we can get some momentum behind these companies and move them forward and during the transition -- as a tennis of my Ph.D. this spring. And begin to move forward on to and accept this is it really going to be. A great boost."
[3:34]" Well we will I know we will hear from you down the line I can only wish you best the very best and especially in this line of research Jeffries just marvelous. Thank you very much thank you very much I would I would do you hail from New England are you from --"
[3:47]" I've been and so and under president MIT and then has started a Ph.D. at UCSD and bioengineering in San Diego. Then came back to MIT. Start a separate Ph.D. here. And before that I was in Virginia and Negroponte taxes."
[4:05]" My gosh Jeffrey. Only -- you thank you so much for telling us your story and it again congratulations thank you very much."
Del.icio.us
Digg
Reddit
